Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 1

Conditions

Skin Neoplasms 1Neoplasms, Squamous Cell 1Immune System Diseases 1Carcinoma, Squamous Cell 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Dimethyl Sulfoxide × Clear all
NCT05932511 2023-08-30

Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer

Center for Biomedical Research, Inc.

Phase EARLY_PHASE1 Unknown
15 enrolled
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms, Neoplasms, Squamous Cell

NCT02519816 2019-08-14

CARE

Maisonneuve-Rosemont Hospital

Phase 2 Unknown
17 enrolled

Immune System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡